Belhaven Biopharma

Belhaven Biopharma is a clinical-stage pharmaceutical company focused on developing innovative treatments, including Nasdepi®, a nasal dry powder epinephrine device designed to treat anaphylaxis. Nasdepi® offers a fast, effective, and painless alternative to traditional epinephrine injections. In clinical trials, Nasdepi® demonstrated rapid drug delivery and comparable efficacy to FDA-approved treatments, positioning it as a potentially revolutionary option for managing severe allergic reactions.